Our group also detected higher levels of survivin expression in cells from CML patients in late chronic-phase CML compared with newly diagnosed (early chronic phase CML patients) (Table 1) [37]. Here, BIRC5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.